Bank of New York Mellon Corp
BankPosition in AMRX — Amneal Pharmaceuticals, Inc.
CIK 1390777
NEW YORK, NY
Position in AMRX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$17,572,796
+$6,210,674 QoQ
Shares Held
1,015,182
+11.1% QoQ
Ownership
0.318%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names. AMRX ranks #13 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,322,319 | $238,741,833 | |
| 2 | VTRS |
Viatris Inc
|
14,288,053 | $226,894,274 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
294,413 | $159,521,790 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
699,125 | $117,830,519 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,411,532 | $83,957,795 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,899,912 | $64,369,013 | |
| 7 | ALKS |
Alkermes plc.
|
1,097,282 | $57,497,573 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
441,831 | $49,016,724 |
All Filings in AMRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,572,796 | 1,015,182 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $11,362,122 | 914,089 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $6,247,682 | 495,848 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $6,008,030 | 600,203 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $4,795,920 | 592,821 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $5,014,497 | 598,389 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $4,940,794 | 623,838 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $5,197,769 | 624,732 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $4,771,406 | 751,403 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $3,773,142 | 622,631 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $3,857,568 | 635,514 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $2,904,886 | 688,362 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $1,947,846 | 628,338 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $643,848 | 463,201 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $969,851 | 487,363 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,187,468 | 587,856 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,715,068 | 539,330 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,361,624 | 566,337 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,683,548 | 560,240 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $3,123,061 | 584,843 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,835,188 | 553,748 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $4,304,123 | 639,543 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $3,540,926 | 774,820 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $3,872,417 | 998,046 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $5,011,194 | 1,052,772 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $4,360,470 | 1,253,009 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||